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Abstract
Background: Thrombotic involvement of the inferior vena cava (IVC) occurs in about 10 % of all patients with renal
cell carcinoma (RCC). It is treated with radical resection of tumor and thrombus. We present the results of a recent
case series of 20 patients with retrohepatic IVC thrombus.
Methods: Our cohort of 20 patients included 16 primary resections (radical nephrectomy and thrombectomy with
and without vascular graft), three recurrences primarily operated on elsewhere (thrombectomy and vascular graft),
and one recurrence due to a new liver metastasis.
Results: All surviving patients were discharged with a patent IVC. The overall mortality rate was 10 %, and the
overall complication rate was 35 %. Both are in keeping with results presented worldwide.
Conclusions: Our series provides a corroborating extension to the existing dataset on RCC-related IVC thrombus
removal. It confirms that the radical surgical approach can be performed safely and successfully with respect to
venous patency.
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Background
Venous involvement, manifesting as tumor thrombus in
the renal vein on the affected side and potentially ex-
tending into the inferior vena cava (IVC) or even the
right atrium is a well-known complication of renal cell
carcinoma (RCC) (Fig. 1). That last category requires
cardiac surgery input due to the requirement for cardio-
pulmonary bypass. The overall incidence is estimated to
be up to 10 % of all renal cancer patients [1] with IVC
involvement more common on the right because the
renal vein is shorter on that side [2] (Fig. 1).
The importance of neoplastic venous thrombosis is
both symptomatic and prognostic. In addition to the
usual symptoms of RCC (flank pain, hematuria, and
symptoms from metastases), patients also suffer the
unpleasant sequelae of IVC obstruction—sometimes
referred to as IVC syndrome—including marked edema
of the IVC-drained territories and hemodynamic
changes due to reduced preload.
While the exact prognostic value of venous involve-
ment is still debated, a few suggestions regarding its im-
portance have been made. Five-year survival rates for
cancer involving the venous system exceeds 50 %—with
reported ranges varying widely from 25 to 70 % [3]. The
characteristics of the underlying tumor, rather than the
presence or level of thrombus, seem to determine prog-
nosis [4]. More importantly, the long-term survival of
patients in whom complete resection is achieved appears
to be markedly better compared to cases with incom-
plete resection [5]. Recurrence of the thrombosis thus
seems to originate from residual thrombus left after
incomplete resection.
From a surgical perspective, involvement of the retro-
hepatic portion of the IVC presents unique technical
challenges. The fragility of the thrombi requires excision
under direct vision, necessitating extensive exposure
of the retrohepatic IVC by mobilizing the right liver
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lobe, dividing its ligaments, and retracting it to the
left (Fig. 2).
The extension of the approach of radical tumor re-
section to cases with venous involvement is generally
considered to be justified based on available data. In-
deed, it is the treatment of choice as practiced by
many centers worldwide. Most importantly, the treat-
ment is best carried out in centralized, tertiary referral
centers with the involvement of a multidisciplinary
team and meticulously tailored perioperative man-
agement [6].
We present a case series of patients who were diag-
nosed with RCC-related IVC thrombosis in the retrohe-
patic portion of the vessel. Our report will complement




From 2007 to 2014, a cohort of 20 patients with RCC-
related venous thrombus in the retrohepatic portion of
the inferior vena cava (IVC) underwent surgical thromb-
ectomy. Diagnosis was established through computed
tomography and ultrasound. Sixteen surgeries were pri-
mary interventions with concomitant ipsilateral radical
nephrectomy. Four cases were reoperations due to re-
current thrombus, three of which had previously been
operated on in other centers. Time from the primary op-
eration to presentation at our department ranged from
3 months to 5 years. The remaining patient who had
been treated in our department 5 years earlier, with
nephrectomy and thrombus removal from the retrohe-
patic portion of the IVC, developed thrombus of the ret-
rohepatic IVC due to a left liver lobe metastasis.
Of patients, 30 % (n = 6) were female and 70 % (n = 14)
were male. Age at time of surgery ranged from 35 to
73 years, with an average of 56 years. The original present-
ing symptoms were hematuria in 75 % of patients (n = 15),
weight loss in 45 % (n = 9), and flank pain in 30 % (n = 6);
20 % (n = 4) had a past history of pulmonary embolism
(PE), and 30 % (n = 6) had suffered deep venous throm-
bosis (DVT) in the lower limbs and IVC below the level of
the renal veins; 35 % had chronic cardiac conditions, 20 %
were diabetic, and 30 % were hypertensive. Among the 16
patients who underwent radical nephrectomy, 2 patients
had a left-sided tumor (12.5 %) and 14 (87.5 %) had a
right-sided tumor. Average tumor size was 13.4 cm, ran-
ging from 6.7 to 16.9 cm. All thrombi extended into the
retrohepatic portion of the IVC. Patient data are detailed
in Table 1.
Procedure
Open operative access was obtained through an inverted
T incision in the upper abdomen. The infrahepatic por-
tion of the inferior vena cava (IVC) was exposed, and
both renal veins were mobilized. The right liver lobe was
mobilized in 19 cases and the left liver lobe in 1 case to
provide access to the retrohepatic portion of the IVC.
The vena cava dissection was carried out cephalad up to
the level of the diaphragm. Intraoperative ultrasound
was used to localize the thrombus within the lumen.
The IVC was clamped inferior to the termination of the
right renal vein. The renal vein on the unaffected side
was also clamped. The hepatoduodenal ligament was
clamped next, and then, the vena cava was clamped
suprahepatically. Finally, the renal vein on the affected
side was clamped. Cavotomy was performed via a longi-
tudinal incision extending between the anterior surface
of the affected renal vein at its point of drainage into the
vena cava and extended to the level of the head of the
thrombus as visualized by intraoperative ultrasound. The
Fig. 1 Left renal vein totally occluded by neoplastic thrombus.
a Wall of the renal vein. b Neoplastic thrombus
Fig. 2 Retrohepatic inferior vena cava (IVC) closed with aid of a
Dacron® graft
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thrombus was excised under direct vision (Fig. 3), and
the IVC wall was inspected for attachment and infiltra-
tion. In case of a positive finding, an IVC wall biopsy
was taken for intraoperative pathological examination.
The posterior wall of the affected renal vein was excised
and the venocavotomy closed with continuous vascular
suture. If the excised circumference of the vessel was
more than half of the original circumference, the defect
in the vessel wall was fixed using a polytetrafluoroethyl-
ene (PTFE) patch (n = 4 patients). In cases where the
pathology report showed tumor infiltration of the IVC
wall, the whole segment affected was resected and re-
placed with a 19-mm reinforced PTFE or Dacron® inter-
position graft (n = 2) (Fig. 3). After the blood flowed
through the IVC and the liver was restored, a radical
nephrectomy was performed on the affected kidney and
renal vein. The specimen obtained was sent for
histopathological examination. The retroperitoneum was
assessed for hemostasis, and a drain was left in place.
All of the patients in the recurrence group underwent
IVC resection with concomitant PTFE grafting. In order
to achieve this, the retrohepatic segment of the IVC was
exposed with ligation and division of all short liver veins
up to their confluence with the right hepatic vein.
After clamping the IVC below the level of the right
renal vein, the left renal vein, and the IVC immediately
below its junction with the right hepatic vein, the af-
fected segment of the IVC was removed along with the
confluence with the renal vein on the affected side by
diagonal incision and replaced with a PTFE patch or
Table 1 Demographic data and disease factors in patients with
advanced renal cell carcinoma and retrohepatic caval thrombus











Prior pulmonary embolism (PE) 4






Left lobe of liver 1
Size of tumor within kidney
Mean 13.4
Range 6.7–16.9




Lymph node involvement 17
IVC wall infiltration 6
Accompany diseases
Chronic heart disease 7
Diabetes 4
Hypertension 6
Fig. 3 Neoplastic thrombus removed from IVC. a Neoplastic
thrombus. b Kidney with neoplasm
Table 2 Postoperative data of patients with advanced renal cell
carcinoma and retrohepatic caval thrombus
Number of patients Percent (%)
Procedure for retrohepatic inferior
vena cava (IVC) associating
nephrectomy
Open thrombectomy 14 70











Acute IVC patency 18 (2 deaths,
patients excluded)
100
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graft. The patient who presented with late metastasis to
the left liver lobe also underwent a left hemihepatect-
omy as part of the procedure. All patients received
1 mg of fractionated heparin per kilogram of body
weight daily during the postoperative period and at the
time of discharge.
Results
The overall mortality rate was 10 %. Of the two deaths
that occurred, one patient undergoing a primary proced-
ure died 5 days after surgery due to cardiopulmonary in-
sufficiency. This patient was preoperatively diagnosed
with chronic coronary disease and had a history of myo-
cardial infarction 3 years prior to the operation. The
other death was due to a brain stem stroke 2 days after
surgery in a patient undergoing a reoperation. IVC pa-
tency at discharge was achieved in all surviving patients.
One patient required reoperation to evacuate a postoper-
ative hematoma. Two patients suffered small pulmonary
emboli. Two patients suffered infection of the operative
wound, which increased their hospital stay by 3 days. The
average blood loss was 768 ml and ranged from 300 to
2380 ml. Three patients, whose blood loss exceeded
1000 ml and who had a history of chronic cardiac condi-
tions, received blood transfusions. In the recurrent
group (excluding the liver metastasis patient), 67 % (two
of three patients) had a thrombus attached to the renal
venous stump.
Of the intraoperative pathology reports, 4 %indicated
tumor invasion into the IVC wall. These patients under-
went extensive excision and subsequent replacement of
the IVC wall with artificial material as described earlier.
A more detailed breakdown is presented in Tables 2 and
3 for the reoperation group.
Discussion
Although IVC thrombus resection is a major operation,
it can be performed relatively safely, considering the
gravity of the underlying disease. Our mortality figure of
10 % corresponds well to the globally reported rates ran-
ging from 2.7 to 13 % [3]. Our overall complication rate
(including fatalities) of 35 % is also within the globally
reported range. For instance, the series with the lowest
mortality rate to date quotes a 30 % complication rate
[5]. The overall results are also consistent with outcomes
achieved in our department when treating neoplastic
thrombus affecting other portions of the IVC [7].
All surviving patients were discharged with a patent
IVC, confirming the technical success of the procedure.
This is particularly reassuring, as the low pressure ven-
ous system is especially sensitive to any changes within
its wall, necessitating close attention to treatment during
the postoperative period as well as after discharge. Given
our results, fractionated heparin injections seem effective
in maintaining patency. It also seems that closure of the
IVC defect by continuous suture, which reduces the final
vessel diameter by less than 50 %, does not affect out-
come in terms of postoperative patency. Similarly, our
series confirms the excellent suitability of PTFE and
Dacron® patching and interposition grafting for the re-
construction of the resected IVC [8].
The finding of thrombus on the renal vein stump in
the recurrent group points to that recurrent thrombus
coming from incomplete original resection. This led us
to adopt the practice of more extensive renal vein resec-
tion during radical nephrectomy, with the aim of also in-
cluding the IVC/renal vein junction. Furthermore, the
case of late RCC metastasis to the left liver lobe and re-
currence of neoplastic thrombus within the retrohepatic
IVC attached to the tumor seems to support the propen-
sity of RCC to venous invasion. Since the invasion in this
case must have originated from the hepatic metastasis, it
is the nature of the tumor rather than its location that
determines its vascular-invasive properties.
Conclusions
We demonstrated the safety and good technical outcome
of RCC-related retrohepatic IVC thrombus resection in
a large cohort of patients in a variety of complex surgical
scenarios.
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Table 3 Reoperation group: recurrence of retrohepatic inferior vena cava (IVC) thrombus
Patient Months since nephrectomy
and first thrombectomy
Staging at first surgery Staging at second surgery Procedure Hospital mortality
GJ 6 pT3N1M0 NxM0 IVC thrombectomy and PTFE graft Day 2
KT 9 pT4N1M0 NxMx IVC thrombectomy and PTFE patch
MP 3 pT3NxMx NxMx IVC thrombectomy and PTFE patch
TJ 61 pT4NxM0 T3NxM1 Left hemihepatectomy, IVC
thrombectomy and PTFE patch
PTFE polytetrafluoroethylene
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